ArticleProceedings of the National Academy of Sciences of the United States of America2023
Structure-function correlates of fibrinogen binding by
Open access · hybridAbstract read
In one paragraph
Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 29 citations in OpenAlex.
- Efficient sequence alignment against millions of prokaryotic genomes with LexicMap.Nature biotechnology · 2026Article
- Network-level divergence in cyclic di-GMP signalling drives ecological versatility in Acinetobacter baumannii.NPJ biofilms and microbiomes · 2026Article
- Role of the AmvAR efflux system on the pathogenesis of Acinetobacter baumannii.Scientific reports · 2026Article
- A quorum-sensing molecule fromProceedings of the National Academy of Sciences of the United States of America · 2026Article
- Attenuation of biofilm-encoding genes and virulence attributes in clinical isolates of Acinetobacter baumannii by essential oil derived from Myroxylon balsamum.Scientific reports · 2026Article
- The Yeh pilus adhesin is equipped with an α-helical flap motif, which contributes to pectin adherence.Science advances · 2026Article
- Antimicrobial susceptibility patterns in Jalisco, Mexico: a snapshot of regional resistance (2021-2023).Frontiers in cellular and infection microbiology · 2026Article
- ENOblock synergizes with colistin to treat Acinetobacter baumannii infections.EMBO molecular medicine · 2025Article
- CAUTIon - not all UTIs are the same.Nature reviews. Urology · 2025Review
- De Novo Design of Miniprotein Inhibitors of Bacterial Adhesins.Research square · 2025Article
- Role of Clot Formation and Plasminogen Activation in Lower Urinary Tract Pathologies.Arteriosclerosis, thrombosis, and vascular biology · 2025Review
- Article
- Vaccination with Acinetobacter baumannii adhesin Abp2D provides protection against catheter-associated urinary tract infection.Nature communications · 2025Article
- Comparative analysis of the performance of the large language models DeepSeek-V3, DeepSeek-R1, open AI-O3 mini and open AI-O3 mini high in urology.World journal of urology · 2025Article
- Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics.Nature reviews. Microbiology · 2025Review
- Phenotypic and genetic heterogeneity ofMicrobial genomics · 2025Article
- Microbial influences on HPV infection and cervical carcinogenesis: emerging evidence from the vaginal microbiome.Frontiers in microbiology · 2025Review
- Glycan-mediated adhesion mechanisms in antibiotic-resistant bacteria.BBA advances · 2025Article
- Investigation of antibiotic resistance and biofilm formation ability ofPakistan journal of medical sciences · 2024Article
- Conformational ensembles inProceedings of the National Academy of Sciences of the United States of America · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 1 country.
Kevin O TamadonfarDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, MO 63110.
Gisela Di VenanzioDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, MO 63110.ORCID 0000-0003-1969-3145
Jerome S PinknerDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, MO 63110.
Karen W DodsonDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, MO 63110.
Vasilios KalasDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, MO 63110.
Maxwell I ZimmermanDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110.
Jesus Bazan VillicanaDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, MO 63110.
Gregory R BowmanDepartment of Biochemistry & Molecular Biophysics, Washington University School of Medicine, St. Louis, MO 63110.
Mario F FeldmanDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, MO 63110.
Scott J HultgrenDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, MO 63110.ORCID 0000-0001-8785-564X
Washington University in St. Louis · USNorthwestern University · US
Funding
NATIONAL RESEARCH SERVICE AWARD-MEDICAL SCIENTISTT32GM007200 · NIGMS · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 1985 to 2024
$59.8MUser Training and OutreachP30GM124169 · NIGMS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI PAUL David ADAMS, Gregory L Hura · 2017 to 2026
$28.6MInfectious Diseases/Basic Microbial Pathogenic MechanismsT32AI007172 · NIAID · WASHINGTON UNIVERSITY · PI Daniel E. Goldberg, JENNIFER A PHILIPS · 1985 to 2026
$13.0MRational design and synthesis of small molecule inhibitors targeting unique pathogenic mechanisms in Gram- and Gram+ bacteria important in UTIU19AI157797 · NIAID · WASHINGTON UNIVERSITY · PI ELLEBEDY, ALI HASSAN · 2021 to 2025
$11.4MPATHOGENIC FIBER FORMATION IN BACTERIA: STRUCTURAL BASISR01AI048689 · NIAID · WASHINGTON UNIVERSITY · PI HULTGREN, SCOTT J. · 2001 to 2020
$7.6MOverall Priority Score P41GM103694 · NIGMS · EMORY UNIVERSITY · PI CUMMINGS, RICHARD D · 2013 to 2018
$6.9MProtein-Glycan Interaction Resource at the National Center for Functional Glycomics (NCFG)R24GM137763 · NIGMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI RICHARD D CUMMINGS · 2020 to 2026
$5.8MMolecular Insights into the Uropathogenesis of MDR Acinetobacter baumanniiR01AI144120 · NIAID · WASHINGTON UNIVERSITY · PI Mario Feldman · 2019 to 2026
$4.1MPathogenic Fiber Formation in Bacteria: Structural BasisR37AI048689 · NIAID · WASHINGTON UNIVERSITY · PI SCOTT J. HULTGREN · 2021 to 2026
$2.9MNIAID NIH HHS R01 AI048689NIAID NIH HHS R01 AI144120NIAID NIH HHS R37 AI048689NIAID NIH HHS T32 AI007172NIAID NIH HHS U19 AI157797NIGMS NIH HHS P30 GM124169NIGMS NIH HHS P41 GM103694NIGMS NIH HHS R24 GM137763NIGMS NIH HHS T32 GM007200
Abstract
Multidrug-resistant
Indexed as
Acinetobacter baumanniiUrinary Tract InfectionsAdhesins, BacterialCathetersFibrinogenHumansAdhesins, BacterialFibrinogenAcinetobacter baumanniiadhesinscatheter-associated urinary tract infectionschaperone-usher pathway pili
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.